<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36163369</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Conformational change of RNA-helicase DHX30 by ALS/FTD-linked FUS induces mitochondrial dysfunction and cytosolic aggregates.</ArticleTitle><Pagination><StartPage>16030</StartPage><MedlinePgn>16030</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16030</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-20405-2</ELocationID><Abstract><AbstractText>Genetic mutations in fused in sarcoma (FUS) cause amyotrophic lateral sclerosis (ALS). Although mitochondrial dysfunction and stress granule have been crucially implicated in FUS proteinopathy, the molecular basis remains unclear. Here, we show that DHX30, a component of mitochondrial RNA granules required for mitochondrial ribosome assembly, interacts with FUS, and plays a crucial role in ALS-FUS. WT FUS did not affect mitochondrial localization of DHX30, but the mutant FUS lowered the signal of mitochondrial DHX30 and promoted the colocalization of cytosolic FUS aggregates and stress granule markers. The immunohistochemistry of the spinal cord from an ALS-FUS patient also confirmed the colocalization, and the immunoelectron microscope demonstrated decreased mitochondrial DHX30 signal in the spinal motor neurons. Subcellular fractionation by the detergent-solubility and density-gradient ultracentrifugation revealed that mutant FUS also promoted cytosolic mislocalization of DHX30 and aggregate formation. Interestingly, the mutant FUS disrupted the DHX30 conformation with aberrant disulfide formation, leading to impaired mitochondrial translation. Moreover, blue-native gel electrophoresis revealed an OXPHOS assembly defect caused by the FUS mutant, which was similar to that caused by DHX30 knockdown. Collectively, our study proposes DHX30 as a pivotal molecule in which disulfide-mediated conformational change mediates mitochondrial dysfunction and cytosolic aggregate formation in ALS-FUS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hikiami</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimura</LastName><ForeName>Toshifumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Center for Animal Life Science, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayaki</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsukiyama</LastName><ForeName>Tomoyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Center for Animal Life Science, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimura</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Integrative Physiology, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusui</LastName><ForeName>Makiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minamiyama</LastName><ForeName>Sumio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shodai</LastName><ForeName>Akemi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asada-Utsugi</LastName><ForeName>Megumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muramatsu</LastName><ForeName>Shin-Ichi</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Tochigi, 320-0498, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-0071, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueki</LastName><ForeName>Takatoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Integrative Anatomy, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urushitani</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. uru@belle.shiga-med.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan. uru@belle.shiga-med.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003902">Detergents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004220">Disulfides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C558578">DHX30 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003902" MajorTopicYN="N">Detergents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>S.M. owns equity in the Gene Therapy Research Institution (a gene therapy company) that commercializes the use of AAV vectors for gene therapy applications. Other authors declare there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36163369</ArticleId><ArticleId IdType="pmc">PMC9512926</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-20405-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-20405-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kwiatkowski TJ, Jr, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, et al. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol. Aging. 2013;34(1312):e1&#x2013;1312.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23046859</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang EJ, et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 2010;20:1069&#x2013;1076. doi: 10.1111/j.1750-3639.2010.00413.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2010.00413.x</ArticleId><ArticleId IdType="pmc">PMC2951498</ArticleId><ArticleId IdType="pubmed">20579074</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, et al. Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science. 2009;324:1729&#x2013;1732. doi: 10.1126/science.1172046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1172046</ArticleId><ArticleId IdType="pubmed">19460965</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L, et al. Isogenic FUS-eGFP iPSC reporter lines enable quantification of FUS stress granule pathology that is rescued by drugs inducing autophagy. Stem Cell Rep. 2018;10:375&#x2013;389. doi: 10.1016/j.stemcr.2017.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.12.018</ArticleId><ArticleId IdType="pmc">PMC5857889</ArticleId><ArticleId IdType="pubmed">29358088</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E, Haass C, Dormann D. Stress granules in neurodegeneration&#x2013;lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 2013;280:4348&#x2013;4370. doi: 10.1111/febs.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12287</ArticleId><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, et al. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. USA. 2018;115:E11904&#x2013;E11913. doi: 10.1073/pnas.1810413115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810413115</ArticleId><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani M, et al. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum. Mol. Genet. 2015;24:773&#x2013;786. doi: 10.1093/hmg/ddu494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu494</ArticleId><ArticleId IdType="pmc">PMC4291251</ArticleId><ArticleId IdType="pubmed">25274782</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, et al. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 2015;43:3208&#x2013;3218. doi: 10.1093/nar/gkv157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv157</ArticleId><ArticleId IdType="pmc">PMC4381066</ArticleId><ArticleId IdType="pubmed">25735748</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonicka H, Sasarman F, Nishimura T, Paupe V, Shoubridge EA. The mitochondrial RNA-binding protein GRSF1 localizes to RNA granules and is required for posttranscriptional mitochondrial gene expression. Cell Metab. 2013;17:386&#x2013;398. doi: 10.1016/j.cmet.2013.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.02.006</ArticleId><ArticleId IdType="pubmed">23473033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jourdain AA, et al. GRSF1 regulates RNA processing in mitochondrial RNA granules. Cell Metab. 2013;17:399&#x2013;410. doi: 10.1016/j.cmet.2013.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.02.005</ArticleId><ArticleId IdType="pmc">PMC3593211</ArticleId><ArticleId IdType="pubmed">23473034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa M, Okazawa H, Yoneda M. Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders. Biochim. Biophys. Acta Gen. Subj. 2021;1865:129832. doi: 10.1016/j.bbagen.2020.129832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2020.129832</ArticleId><ArticleId IdType="pubmed">33358866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum. Mol. Genet. 2016;25:5059&#x2013;5068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078632</ArticleId><ArticleId IdType="pubmed">27794540</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, et al. FUS interacts with HSP60 to promote mitochondrial damage. PLOS Genet. 2015;11:e1005357. doi: 10.1371/journal.pgen.1005357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005357</ArticleId><ArticleId IdType="pmc">PMC4559378</ArticleId><ArticleId IdType="pubmed">26335776</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R, et al. ALS/FTD-associated FUS activates GSK-3beta to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 2016;17:1326&#x2013;1342. doi: 10.15252/embr.201541726.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541726</ArticleId><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bogenhagen DF. Human mitochondrial DNA nucleoids are linked to protein folding machinery and metabolic enzymes at the mitochondrial inner membrane. J. Biol. Chem. 2006;281:25791&#x2013;25802. doi: 10.1074/jbc.M604501200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M604501200</ArticleId><ArticleId IdType="pubmed">16825194</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonicka H, Shoubridge EA. Mitochondrial RNA granules are centers for posttranscriptional RNA processing and ribosome biogenesis. Cell Rep. 2015;10:920&#x2013;932. doi: 10.1016/j.celrep.2015.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.01.030</ArticleId><ArticleId IdType="pubmed">25683715</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikiami R, et al. Amyotrophic lateral sclerosis after Receiving the Human Papilloma Virus Vaccine: A case report of a 15-year-old girl. Intern. Med. 2018;57:1917&#x2013;1919. doi: 10.2169/internalmedicine.0285-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.0285-17</ArticleId><ArticleId IdType="pmc">PMC6064690</ArticleId><ArticleId IdType="pubmed">29434138</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J. Biol. Chem. 2013;288:25266&#x2013;25274. doi: 10.1074/jbc.M113.492017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.492017</ArticleId><ArticleId IdType="pmc">PMC3757190</ArticleId><ArticleId IdType="pubmed">23867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessel D, et al. De novo missense mutations in DHX30 impair global translation and cause a neurodevelopmental disorder. Am. J. Hum. Genet. 2017;101:716&#x2013;724. doi: 10.1016/j.ajhg.2017.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.09.014</ArticleId><ArticleId IdType="pmc">PMC5673606</ArticleId><ArticleId IdType="pubmed">29100085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaki Y, et al. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals. Sci. Rep. 2018;8:6030. doi: 10.1038/s41598-018-24463-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24463-3</ArticleId><ArticleId IdType="pmc">PMC5902603</ArticleId><ArticleId IdType="pubmed">29662239</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, et al. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc. Natl. Acad. Sci. USA. 2018;115:E9678&#x2013;E9686. doi: 10.1073/pnas.1806655115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806655115</ArticleId><ArticleId IdType="pmc">PMC6187197</ArticleId><ArticleId IdType="pubmed">30249657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, et al. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4748&#x2013;4755. doi: 10.1093/hmg/ddt328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt328</ArticleId><ArticleId IdType="pubmed">23847048</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat. Med. 2022;28:104&#x2013;116. doi: 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HJ, et al. The novel helicase helG (DHX30) is expressed during gastrulation in mice and has a structure similar to a human DExH box helicase. Stem Cells Dev. 2015;24:372&#x2013;383. doi: 10.1089/scd.2014.0077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2014.0077</ArticleId><ArticleId IdType="pubmed">25219788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci I, et al. Genotype&#x2013;phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders. Genome Med. 2021;13:90. doi: 10.1186/s13073-021-00900-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00900-3</ArticleId><ArticleId IdType="pmc">PMC8140440</ArticleId><ArticleId IdType="pubmed">34020708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye P, Liu S, Zhu Y, Chen G, Gao G. DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein Cell. 2010;1:956&#x2013;964. doi: 10.1007/s13238-010-0117-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0117-8</ArticleId><ArticleId IdType="pmc">PMC4875121</ArticleId><ArticleId IdType="pubmed">21204022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology. 2008;372:97&#x2013;106. doi: 10.1016/j.virol.2007.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.10.027</ArticleId><ArticleId IdType="pubmed">18022663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzotto D, et al. Nutlin-induced apoptosis is specified by a translation program regulated by PCBP2 and DHX30. Cell Rep. 2020;30:4355&#x2013;4369.e4356. doi: 10.1016/j.celrep.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7182397</ArticleId><ArticleId IdType="pubmed">32234473</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos IG, et al. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 2005;25:164&#x2013;172. doi: 10.1523/JNEUROSCI.3829-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3829-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725219</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>